Search results

Showing 1 – 50 of 144 results.
Curated
Restricted

Abstinence Reinforcing Contingency Management to Suppress HIV Viral Load (Project First), New York City, 2012 (ICPSR 39785)

Released/updated on: 2026-04-20
Geographic coverage: New York City, United States, New York (state)

This study is part of the Seek, Test, Treat and Retain (STTR) Collaboration Project that involved over twenty studies in the fields of HIV and drug abuse. All studies were independently developed, but were chosen for the collaboration because they focused on one or more steps of the HIV treatment cascade: Seek, Test, Treat and Retain. As part of STTR Collaboration Project, the studies were grouped into Criminal Justice-related studies and Vulnerable Population-related studies. The data collected by these studies included twelve common domains (e.g., Demographic characteristics, Mental Health) in each of which a shared questionnaire or instrument was taken up by the studies and adapted to fit the study.

Using a randomized controlled study design, this study tested the efficacy of an abstinence-reinforcing CM intervention compared with a control condition (performance feedback) on HIV viral load (VL) suppression. The intervention CM group could receive up to $1320 in vouchers over the 16-week intervention based on drug-free urine. Participants were followed for 28 weeks (44 visits), with research visits occurring twice weekly during the Baseline Period (weeks 1-4, visits 1-8) and Intervention Period (weeks 5-20, visits 9-40), then every two weeks during the Post-Intervention Period (weeks 21-28, visits 41-44).

Curated

Adolescent Health and Development in Context (AHDC) Study, Franklin County, Ohio, Wave 1, 2014-2016 (ICPSR 39045)

Released/updated on: 2024-07-23
Geographic coverage: United States, Columbus (Ohio), Ohio
Time period: 2014-01-01--2016-01-01
The overarching objective of the Adolescent Health and Development in Context (AHDC) Project is to collect multilevel, multi-contextual data on a large sample of 1,405 youth ages 11 to 17 years in Franklin County, Ohio. The study emphasizes the interplay of social, psychological, and biological processes in shaping youth developmental outcomes such as risk behavior and victimization, mental and physical health, and educational outcomes. The study employs a prospective cohort design in which the data on youth and caregivers were collected at two time-points, approximately one year apart. The Wave 1 field period began in spring 2014 and was completed in summer 2016. Wave 2 was conducted between January and December 2016. Within each wave, participant data were collected over a weeklong period. An Entrance Survey with both a focal youth and his or her caregiver was followed by a seven-day smartphone-based Global Positioning System (GPS) tracking and EMA data collection period (EMA Week), and a final Exit Survey at the end of the week.
Curated
Partially restricted

Adolescent Substance Abuse Prevention Study (ASAPS), 2001-2006 [Detroit, Houston, Los Angeles, Newark, New Orleans, St. Louis] (ICPSR 28641)

Released/updated on: 2012-02-29
Geographic coverage: Detroit, United States, New Orleans, Los Angeles, Newark, St. Louis, Houston
Time period: 2001-01-01--2006-01-01

The Adolescent Substance Abuse Prevention Study (ASAPS) was a randomized field trial designed to test the effectiveness of a new school-based substance abuse prevention program called Take Charge of Your Life (TCYL). The program consisted of two curricula, one for middle schools and the other for high schools, which were delivered through the Drug Abuse Resistance Education network of law enforcement officers (D.A.R.E.). TCYL was developed building on existing D.A.R.E. seventh/eighth grade and tenth/eleventh grade curricula and applied principles and strategies suggested by published literature on effective drug abuse prevention programming and effective middle and high school curricula design. ASAPS was conducted among a 2001-2002 multi-site cohort of seventh graders who were followed for five years until the 2005-2006 school year when they were in the eleventh grade. The first TCYL curriculum was delivered in the treatment schools when the students were in seventh grade and the second was delivered when they were in the ninth grade.

Over the five-year study period, the treatment and control students responded to seven self-administered surveys: (1) at baseline in the seventh grade, (2) post-intervention in the seventh grade, (3) in the eighth grade, (4) pre-intervention in the ninth grade, (5) post-intervention in the ninth grade, (6) in the tenth grade, and (7) in the eleventh grade. Topics covered by the surveys include normative beliefs, social skills, attitudes toward drug use, and self-reported use of alcohol, tobacco, marijuana, and other illicit drugs. The ASAPS data also include measures of implementation fidelity of the seventh and ninth grade TCYL curricula, which were obtained from trained observers who rated the D.A.R.E. officers' delivery in the classroom. The fidelity measures encompass content coverage and instructional strategy.

This data collection comprises two data files, both with public- and restricted-use versions. The first (the Main Data File) contains the students' survey responses and the seventh grade curriculum fidelity measures, while the second (the 9th Grade Officer Observations Data) contains the ninth grade curriculum fidelity measures.

Curated

Alcohol and Drug Services Study (ADSS), 1996-1999: [United States] (ICPSR 3088)

Released/updated on: 2009-04-01
Geographic coverage: United States
Time period: 1996-01-01--1999-01-01
The Alcohol and Drug Services Study (ADSS) was a national study of substance abuse treatment facilities and clients. The study was designed to develop estimates of the duration and costs of treatment and to describe the post-treatment status of substance abuse clients. ADSS continues and extends upon data collected in the Drug Services Research Survey, 1990: [United States] (ICPSR 3393) and the Services Research Outcome Study, 1995-1996: [United States] (ICPSR 2691) with a more complete sampling frame, an enhanced sampling design, and more detailed measures of treatment services provided, the costs of treatment, and clients in treatment. ADSS was implemented in three phases. In Phase I, a nationally representative sample of treatment facilities was surveyed to assess characteristics of treatment services and clients including treatment type, costs, program capacity, the number of clients served, waiting lists, and services provided to special populations. In Phase II, records were abstracted from a sample of clients in a subsample of Phase I facilities. This phase included four sub-components: (1) the Main Study, an analysis of abstracted records to assess the treatment process and characteristics of discharged clients, (2) the Incentive Study, which assessed the impact of varying financial payments on follow-up interview participation among non-methadone outpatient clients, (3) the In-Treatment Methadone Client study (ITMC), which assessed the treatment process of methadone maintenance, and (4) the comparison study of Early Dropout clients (EDO), which provided a proxy comparison group of records from substance abusers that went untreated. Phase III involved follow-up personal interviews with Phase II clients who could be located. This interview sought to determine post-treatment status in terms of substance use, economic condition, criminal justice involvement, and further substance abuse treatment episodes. Urine testing was conducted to validate self-reported drug use. Drugs included in the survey were alcohol, marijuana, cocaine, crack cocaine, heroin, barbiturates, benzodiazepines, amphetamines, non-prescribed use of prescription medications, abuse of over-the-counter medications, and other drugs. ADSS also included a cost study, which involved obtaining additional financial information from the Phase II facilities. A computerized desktop audit was used in the cost study to conduct consistency and accuracy checks on selected questionnaire data from Phases I and II. Variables were subsequently updated to represent the most accurate data available. Additional analysis variables were then created using combinations of the revised Phase I and II data.
Curated

Arrestee Drug Abuse Monitoring (ADAM) Project in Rural Nebraska, 1998 (ICPSR 28141)

Released/updated on: 2011-01-28
Geographic coverage: Omaha, United States, Nebraska
Time period: 1998-10-01--1998-11-01
A pilot outreach project of the National Intstitute of Justice's Arrestee Drug Abuse Monitoring (ADAM) program, the rural Nebraska ADAM program examined the prevalence and type of arrestee drug use in four rural Nebraska counties and compared the results to those found in Omaha, Nebraska, an established ADAM site. The data were collected in Madison (n=78), Dawson (n=50), Hall (n=53), and Scotts Bluff (n=149) counties, and Omaha, Nebraska, (n=202) in October and November of 1998. The catchment area for Omaha was the central city. The ADAM interview provided demographic and descriptive data, including race, age, marital status, source of income, screens of substance abuse and dependency, treatment history, arrest and incarceration experiences, and participation in local drug markets. At the conclusion of the interview, respondents were asked to provide a urine specimen. The current study included a supplemental questionnaire about methamphetamine use. The methamphetamine addendum included variables on why the respondent began and continued the use of methamphetamines, how often and how much methamphetamine was used, if and why the respondent had ever sought and completed treatment, source of the methamphetamine, and if the respondent had ever made or sold methamphetamine.
Curated

Arrestee Drug Abuse Monitoring II in the United States, 2012 (Restricted Use) (ICPSR 34821)

Released/updated on: 2013-08-29
Geographic coverage: New York City, Sacramento, United States, Chicago, Atlanta, Illinois, Colorado, Denver, California, Georgia, New York (state)
Time period: 2012-04-30--2012-07-29
The Arrestee Drug Abuse Monitoring II, 2012 is a collection of interview and bioassay data provided by over 3000 arrestees from five county sites within the United States. Under the sponsorship of the Office of National Drug Control Policy (ONDCP), the ADAM II program monitors drug use and related behaviors (treatment experiences, housing stability, drug market activity, age at first use, employment, etc.) in a probability based sample of male adult arrestees within 48 hours of their arrest. The five ADAM II sites for 2012 were: Atlanta, GA (Fulton County and the City of Atlanta); Chicago, IL (Cook County); Denver, CO (Denver County); New York, NY (Borough of Manhattan); and Sacramento, CA (Sacramento County). The 2012 survey represents the sixth year of ADAM II and includes data from 1,938 interviews and 1,736 urine tests that were conducted at the five ADAM II sites over a 21-day period, between April 30 and July 29, 2012. The samples from these sites were weighted to represent over 14,000 arrests of adult males in the five counties. ADAM II data include official records, arrestee responses from a 20-minute face-to-face interview, and results from voluntary urine samples which tested for the presence of nine different drugs. Identifying information on the arrestees was not retained or shared with law enforcement. Demographic variables include age, gender, race, arrest date and time, county of arrest, number and type(s) of offense(s), education, work status, and language of interview.
Curated

Arrestee Drug Abuse Monitoring Program II in the United States, 2007 (ICPSR 25821)

Released/updated on: 2010-01-28
Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis
Time period: 2007-04-01--2007-09-01
The Arrestee Drug Abuse Monitoring (ADAM) II program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, the ONDCP and Abt Associates have initiated a new data collection that replicates the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. A total of 8,296 arrestees were interviewed during the second and third quarters of 2007. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. The Arrestee Drug Abuse Monitoring (ADAM) II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.
Curated

Arrestee Drug Abuse Monitoring Program II in the United States, 2008 (ICPSR 27221)

Released/updated on: 2010-03-31
Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis
The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc. have initiated a new data collection that replicates the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implements two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collects data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. Data collection has been conducted across two back-to-back quarters in each of 10 counties from a county-based representative sample of 250 male arrestees per quarter for a total of 500 arrestees annually per site or a total of 5,000 arrestees across sites annually. A total of 7,717 arrestees were interviewed during the second and third quarters of 2008. Collection occurs in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2007 and ending March 31, 2008. Additional data collection periods were optioned by ONDCP, and subsequent cycles of back-to-back data collection (not yet available) began April 1, 2008. Participation is voluntary and confidential, and the procedures include a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.
Curated

Arrestee Drug Abuse Monitoring Program II in the United States, 2009 (ICPSR 30061)

Released/updated on: 2011-02-24
Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis
The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc., initiated a new data collection that replicated the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. A total of 7,794 arrestees were interviewed during the second and third quarters of 2009. Collection occurred in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2009, and ending September 30, 2009. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.
Curated

Arrestee Drug Abuse Monitoring Program II in the United States, 2010 (ICPSR 32321)

Released/updated on: 2011-11-04
Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis
The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc., initiated a new data collection that replicated the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. A total of 8,332 arrestees were interviewed during the second and third quarters of 2010. Collection occurred in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2010, and ending September 30, 2010. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.
Curated

Assessing the Texas Christian University Drug Screen Instrument with Texas Department of Criminal Justice Inmates, 1999-2000 (ICPSR 3541)

Released/updated on: 2003-06-05
Geographic coverage: United States, Texas
Time period: 1999-01-01--2000-01-01
The overall purpose of this study was to examine the psychometric properties and credibility of the Texas Christian University (TCU) Drug Screen as an instrument to assess drug use severity for treatment referral decisions in correctional settings. TCU Drug Screen data were collected on 18,364 Texas Department of Criminal Justice (TDCJ) inmates (15,816 males and 2,548 females) who completed the screen between January 1 and April 30, 1999. Of the 18,364 subjects, 13,902 were Institutional Division (TDCJ-ID) inmates and 4,462 were State Jail Division (TDCJ-SJD) inmates. The TCU Drug Screen was administered by TDCJ staff almost exclusively in a small group setting (12-25 inmates per group) as part of a larger battery of assessments during the intake process at a TDCJ facility. The level and intensity of treatment services needed was then determined and a referral decision was made. As part of this study, the relationship between TCU Drug Screen information and post-release reincarceration was examined. Although one original goal in the study was to assess the comparability, or concurrent validity, of the TCU Drug Screen with the lengthier, more comprehensive Addiction Severity Index (ASI), TDCJ changed the administration protocol for the ASI so that it was given only to a subsample of 3,245 inmates who failed to disclose drug use problems on the TCU Drug Screen. The data include inmate responses to all items of the TCU Drug Screen and the overall drug screen score. There is also demographic information as well as incarceration, release, and reincarceration data.
Curated

Assessing Washington State's Models to Increase Use of Medications for Opioid Use Disorder: Hub and Spoke and Low-Barrier Opioid Treatment Networks, 2015-2022 (ICPSR 39817)

Released/updated on: 2026-04-13
Geographic coverage: United States, Washington
Time period: 2015-07-01--2022-12-31

MOUD remains an underutilized evidence-based practice with potential to reduce opioid use disorder (OUD) and save lives. Washington State expanded its Hub & Spoke (H&S) model for OUD medication treatment (MOUD: buprenorphine, methadone, naltrexone) by funding additional networks and developing a low-barrier, Opioid Treatment Network (OTN) model. The Washington H&S model was designed as a flexible approach incorporating primary care and substance use treatment programs, referral organizations, nurse care managers and care navigators. The OTN model offers MOUD induction in non-traditional settings (e.g., emergency departments, jails) with connections to community partners who will offer MOUD maintenance.

This study examined the implementation and effectiveness of the H&S and OTN models for increasing MOUD treatment and improving outcomes for people with OUD. Washington's H&S and OTN interventions were funded through federal STR/SOR opioid response grants, and the expanded H&S networks were funded through the state. The study, Hub and Spoke Opioid Treatment Networks: 2nd Generation Approaches to Improve Medication Treatment for Opioid Use Disorders (R01DA0561067), and its supplement (R01DA0561067S1) was part of NIH's HEAL initiative, and built on an earlier study (R33DA045851). All three studies were supported by the National Institute on Drug Abuse.

Expanding Access to Low-Barrier Opioid Use Disorder Treatment in Non-Traditional Settings: Washington's Opioid Treatment Network

  • Increasing utilization of medications that treat opioid use disorders (MOUD) remains an essential strategy to curb the opioid crisis nationwide, especially among rural areas where access can present challenges. Washington State expanded access to MOUD through its opioid treatment networks (OTN), which provide low-barrier access to MOUD in non-traditional settings with an emphasis on buprenorphine and rural locations. The study examined changes in buprenorphine utilization between Medicaid beneficiaries who initiated treatment at OTNs compared to individuals outside OTN facilities and by rural-urban residence.

Differential Changes in Use of Medications for Opioid Use Disorder by Race-Ethnicity: Effects of a Hub-and-Spoke Model

  • This study assessed whether delivery of opioid use disorder (OUD) treatment through a hub and spoke (HS) model is associated with better adherence to psychotropic medication treatment, compared to usual treatment. Washington State's HS model required each network to include at least one mental health program, so it was hypothesized that it would improve psychotropic medication adherence for people with both a mental health disorder (MHD) and an OUD.

Treatment for Comorbid Mental Health Disorders Among Patients Treated for Opioid Disorder: The Role of a Hub and Spoke Intervention

  • The research team examined, separately for different racial-ethnic groups, whether use of medications for opioid use disorder (MOUD) increased more among people treated in a hub-and-spoke care model than among people treated in a non-hub-and-spoke model.
Curated

California Families Project [Sacramento and Woodland, California] [Restricted-Use Files] (ICPSR 35476)

Released/updated on: 2017-03-08
Geographic coverage: Sacramento, United States, California
Time period: 2006-01-01--2007-01-01

The California Families Project (CFP) is an ongoing longitudinal study of Mexican origin families in Northern California. This study uses community, school, family, and individual characteristics to examine developmental pathways that increase risk for and resilience to drug use in Mexican-origin youth. This study also examines the impact that economic disadvantage and cultural traditions have in Mexican-origin youth. The CFP includes a community-based sample of 674 families and children of Mexican origin living in Northern California, and includes annual assessments of parents and children. Participants with Mexican surnames were drawn at random from school rosters of students during the 2006-2007 and 2007-2008 school year. Data collection included multi-method assessments of a broad range of psychological, familial, scholastic, cultural, and neighborhood factors. Initiation of the research at age 10 was designed to assess the focal children before the onset of Alcohol, Tobacco, and Other Drug (ATOD) use, thus enabling the evaluation of how hypothesized risk and resilience mechanisms operate to exacerbate early onset during adolescence or help prevent its occurrence. This study includes a diversity of families that represent a wide range of incomes, education, family history, and family structures, including two-parent and single-parent families.

The accompanying data file consists of 674 family cases with each case representing a focal child and at least one parent (Two-parent: n=549, 82 percent; Single-parent: n=125, 18 percent). Of the 3,139 total variables, 839 pertain to the focal child, 1,376 correspond to the mother, and 908 items pertain to the father.

Please note: While the California Families Project is a longitudinal study, only the baseline data are currently available in this data collection.

Curated

Center for Education and Drug Abuse Research (CEDAR): Etiological and Prospective Family Study in Southwestern Pennsylvania, Baseline and Follow-Up Data, 1990-2014 (ICPSR 33444)

Released/updated on: 2021-06-30
Geographic coverage: United States, Pennsylvania
Time period: 1990-01-01--2014-01-01
The Center for Education and Drug Abuse Research (CEDAR) conducted research on 775 families enrolled in the Center's prospective investigations into the etiology of substance use disorder (SUD). The pro-bands are men with lifetime presence/absence of SUD consequent to use of an illicit drug who have a 10-12 year old biological son or daughter. The biological children of SUD men are assigned to the high average risk (HAR) group whereas offspring of men without SUD, having neither axis 1 disorder ("normal") nor SUD psychiatric disorder, are assigned to the low average risk (LAR) group. A second control group (Psych control) was also collected, in whom the fathers had a lifetime DSM-III-R diagnosis of any psychiatric disorder not related to substance use. The sample sizes are as follows: HAR = 344, LAR = 350, and Psych = 81. The children had follow-up evaluations conducted at ages 12-14, 16, 19, and annually thereafter until age 30. CEDAR has already shown that they can predict in 10-12 year old youth cannabis use disorder by age 22 with approximately 70 percent accuracy, thereby substantiating the paradigm, subject recruitment strategy, and measurement protocols. Multidisciplinary research was conducted on family members (father, mother, children) with the objective of elucidating the genetic, bio-behavioral, and environmental factors on development of SUD consequent to use of illegal drugs. Research protocols are organized into three thematically connected research modules (Neurogenetics, Developmental Psychopathology, and Translation) linking etiology and prevention. The research components thus align with the NIH Roadmap model such that basic science informs clinical research leading to prevention guided by an understanding of etiology. In addition to module-level research, faculty also participate in three organizational aims: (1) Devise a practical scale to quantify the transmissible liability to SUD; (2) Empirically test a bio-psychological theory of SUD etiology focusing on off-time maturation leading to psychological dysregulation predisposing to SUD; and, (3) Delineate SUD liability variants within an ontogenetic framework.
Curated
Simple Crosstabs

The Community Vulnerability and Responses to Drug-User-Related HIV/AIDS, 1990-2013 [96 Metropolitan Statistical Areas, United States] (ICPSR 36575)

Released/updated on: 2017-08-08
Geographic coverage: North Carolina, Milwaukee, Indiana, Ocean (New Jersey), Fort Worth, Cincinnati, Austin, Monmouth (New Jersey), Utah, San Jose, Rock Hill, Gastonia, San Diego, Columbus (Ohio), Syracuse, Springfield (Massachusetts), North Little Rock (Arkansas), Arizona, Las Vegas, Arlington, Springfield (Ohio), Boston, San Bernardino, Providence, Seattle, Kentucky, St. Petersburg, Bethlehem, Niagara Falls (New York), Nashville, California, Florida, Delaware, Hunterdon (New Jersey), Boca Raton (Florida), Troy, Knoxville, Mississippi, Fresno, New Haven, Sarasota, Illinois, Newark, Georgia, Little Rock, Virginia, Maryland, Norfolk, Virginia Beach, Suffolk County (New York), United States, Oklahoma, Grand Rapids, Louisville, Waukesha (Wisconsin), Arkansas, Washington, South Carolina, Albany (New York), Wichita, Mesa (Arizona), Carlisle (Pennsylvania), Fall River, Massachusetts, Missouri, Winston-Salem, Holland (Michigan), New Orleans, Scranton, Denver, Salt Lake City, Harrisburg, Dallas, St. Louis, Nevada, Schenectady, Allentown, Raleigh, San Antonio, Muskegon, St. Paul, Clearwater, Hawaii, Rochester (New York), Passaic, Ventura (California), Birmingham, Michigan, Lebanon, Baltimore, New Mexico, Orlando, Louisiana, Toledo, Middlesex (New Jersey), Philadelphia, Riverside, Oklahoma City, Akron, Greensboro, Detroit, Charlotte, High Point, Tucson, Albuquerque, Everett, Oakland, Bakersfield, New York City, Somerset (New Jersey), Petersburg, Memphis, Ogden, Jacksonville, Buffalo, Pittsburgh, Nassau (New York), Orange County (California), Sacramento, El Paso, Greenville, Kansas, Meriden, Pennsylvania, Tulsa, Chapel Hill (North Carolina), West Palm Beach, Iowa, Texas, Lorain, Portland (Oregon), Hazleton, Tampa, Durham, San Marcos (Texas), Indianapolis, Richmond, Oregon, Warwick, Bergen (New Jersey), Newport News, Ann Arbor, Alabama, Cleveland, Dayton, Nebraska, Omaha, Warren, West Virginia, Elyria, Tacoma, Minneapolis, Youngstown, Atlanta, Honolulu, Phoenix, Bradenton, Wilmington (Delaware), Gary, District of Columbia, Rhode Island, Vancouver (Washington), Lodi (California), Chicago, Fort Lauderdale, Wilkes-Barre, Minnesota, Kansas City (Missouri), Bellevue, New York (state), Anderson, New Jersey, Miami, San Francisco, Charleston (South Carolina), Jersey City, Long Beach, Spartanburg (South Carolina), New Hampshire, Easton, Ohio, Los Angeles, Hartford, Stockton, Houston
Time period: 1990-01-01--2013-01-01

The Community Vulnerability and Responses to Drug-User-Related HIV/AIDS, 1990-2013 [96 Metropolitan Statistical Areas, United States] study (CVAR) was a research study of why large United States Metropolitan Statistical Areas (MSAs) vary over time in their vulnerability to HIV/AIDS among drug users and in MSA responses to HIV/AIDS. This collection contains estimates of HIV prevalence among people who injected drugs (PWID) and among sub-populations of PWID. This collection is comprised of ten datasets with differing amounts of variables and provides trend data that describe the following:

  • Epidemiologic outcomes including population prevalence of PWIDs and Non-injecting drug users (NIDUs), and particularly their prevalence among youth; and, among PWIDs, HIV prevalence, late-diagnosis HIV cases, and AIDS incidence and mortality.
  • Implementation of evidence-based drug-related interventions including drug abuse treatment, syringe exchange, HIV counseling and testing.
  • Implementation of non-evidence-based drug-related interventions including incarceration and arrests of drug users.

The collection contains data on the MSA sub-populations including Black, Hispanic, White and "other" race categories. In addition, some statistics are presented in age range categories such as ages 15-29, 30-64 and 15-64.

Curated

Consequences of Recent Parental Divorce for Young Adults, 1990-1992 (ICPSR 24400)

Released/updated on: 2010-03-12
Geographic coverage: United States, Maryland
Time period: 1990-01-01--1992-01-01
This longitudinal study focused on examining the consequences of recent parental divorce for young adults (initially ages 18-23) whose parents had divorced within 15 months of the study's first wave (1990-91). The sample consisted of 257 White respondents with newly divorced parents and 228 White respondents who comprised an intact-family comparison group. A life course framework guided the study that focused heavily on young adult transition behaviors (entries and exits from home, work, school, cohabitation and marriage relationships, parenthood), family relationships (relationships with mother and father, siblings, grandparents), and well-being and adjustment (depression, coping). For respondents in the divorced-parents group, additional questions were asked about specific aspects of the divorce and their involvement in it. A follow-up telephone interview conducted two years later assessed life changes and subsequent adjustment over time for both groups of respondents. Specific questions addressed the sexual history of respondents and their most recent sexual partner, including the perceived risk of HIV/AIDS, history of sexual transmitted disease, the use of contraception, how much information they had shared with each other regarding their sexual attitudes and behaviors, and respondent's knowledge of the AIDS virus. Information was also collected on marital/cohabitation history, employment history, reproductive history, including the number and outcome of all pregnancies, physical and mental health, and tobacco, alcohol and drug use. Demographic variables include respondent's sex, age, occupation, employment status, marital/cohabitation status, number of children, current enrollment in school, past and present religious preferences, frequency of religious attendance, military service, and the number, sex, and age of siblings. Demographic information also includes the age, education level, employment status, and annual income of the respondent's parents, as well as the age, race, and education level of the respondent's most recent sexual partner. For those respondents whose parents were recently divorced, demographic information was collected on each parent's current marital status and the age of their new spouse or partner.
Curated

Cooperative Agreement for AIDS Community-Based Outreach/Intervention Research Program, 1992-1998: [United States] (ICPSR 3023)

Released/updated on: 2008-10-23
Geographic coverage: United States
Time period: 1992-01-01--1998-01-01
The purpose of the Cooperative Agreement (CA) Research Program was to monitor risk factors, risk behaviors, and rates of HIV seroprevalence and seroincidence among out-of-treatment, multi-ethnic/racial injection drug users and crack cocaine users. The program evaluated the efficacy of experimental interventions designed to prevent, eliminate, or reduce HIV risk behaviors and developed new treatment interventions. All participants received the standard intervention, which consisted of street-based outreach and HIV prevention counseling. Those assigned to enhanced interventions received more counseling sessions, educational videos, social gatherings, and support group activities. The public-use data file contains 31,088 respondent records, collected from 21 CA program facilities in the United States and one facility each in Puerto Rico and Brazil. Hence, the process data file contains 23 records of facility information that can be linked to individual respondents. Respondent interviews include a baseline Risk Behavior Assessment (completed prior to first intervention) and a Follow-Up Assessment, conducted either three months or six months after the baseline survey. Respondent data were augmented with eligibility information, biological markers of drug use, HIV test results, and intervention assignment. At baseline and post-intervention, the surveys measured drug use and drug treatment, sexual activity and sex for money/drugs, arrests, work/income, HIV/STD/pregnancy status, perceptions of risk, and risk reduction behaviors. The process questionnaires were completed by staff or principal investigators at the 23 site locations. Process data describe the program structure and process, other intervention projects in the community, needle exchange programs and pharmacy syringe sales, and local HIV infection rates. Drugs reported on include alcohol, marijuana/hashish, crack/cocaine, heroin (including speedball), non-prescription methadone, other opiates, and amphetamines.
Curated

Crack, Powder Cocaine, and Heroin: Drug Purchase and Use Patterns in Six Cities in the United States, 1995-1996 (ICPSR 2564)

Released/updated on: 2012-08-22
Geographic coverage: New York City, Oregon, District of Columbia, San Diego, San Antonio, United States, Chicago, Illinois, Texas, Portland (Oregon), California, New York (state)
Time period: 1995-01-01--1996-01-01
This study was designed to address the practical and policy implications of various drug market participation patterns. In 1995, the Office of National Drug Control Policy (ONDCP) and the National Institute of Justice (NIJ) collaborated on a project called the Procurement Study. This study was executed as an addendum to NIJ's Drug Use Forecasting (DUF) program (DRUG USE FORECASTING IN 24 CITIES IN THE UNITED STATES, 1987-1997 [ICPSR 9477]) with the goal of extending previous research in which heroin users were interviewed on various aspects of drug market activity. The present study sought to explore additional features of drug market participation and use, both within and across drug types and cities, and included two additional drugs -- powder cocaine and crack cocaine. Data were collected from recently arrested users of powder cocaine, crack cocaine, and heroin in six DUF cities (Chicago, New York, Portland, San Diego, San Antonio, and Washington, DC). Each of the three files in this collection, Crack Data (Part 1), Heroin Data (Part 2), and Powder Cocaine Data (Part 3), is comprised of data from a procurement interview, urine test variables, and a DUF interview. During the procurement interview, information was collected on purchase and use patterns for specific drugs. Variables from the procurement interview include the respondent's method of using the drug, the term used to refer to the drug, whether the respondent bought the drug in the neighborhood, the number of different dealers the respondent bought the drug from, how the respondent made the connection with the dealer (i.e., street, house, phone, beeper, business/store, or friends), their main drug source, whether the respondent went to someone else if the source was not available, how the respondent coped with not being able to find drugs to buy, whether the respondent got the drug for free, the means by which the respondent obtained money, the quantity and packaging of the drug, and the number of minutes spent searching for, traveling to, and waiting for their last purchase. Urine tests screened for the presence of ten drugs, including marijuana, opiates, cocaine, PCP, methadone, benzodiazepines (Valium), methaqualone, propoxyphene (Darvon), barbiturates, and amphetamines (positive test results for amphetamines were confirmed by gas chromatography). Data from the DUF interview provide detailed information about each arrestee's self-reported use of 15 drugs. For each drug type, arrestees were asked whether they had ever used the drug, the age at which they first used the drug, whether they had used the drug within the past three days, how many days they had used the drug within the past month, whether they had ever needed or felt dependent on the drug, and whether they were dependent on the drug at the time of the interview. Data from the DUF interview instrument also included alcohol/drug treatment history, information about whether arrestees had ever injected drugs, and whether they were influenced by drugs when the crime that they were charged with was committed. The data also include information about whether the arrestee had been to an emergency room for drug-related incidents and whether he or she had had prior arrests in the past 12 months. Demographic data include the age, race, sex, educational attainment, marital status, employment status, and living circumstances of each respondent.
Curated
Simple Crosstabs

Criminal Justice Drug Abuse Treatment Studies 2: Medication-Assisted Therapy, 2010-2013 [United States] (ICPSR 34988)

Released/updated on: 2016-02-02
Geographic coverage: Rhode Island, Puerto Rico, United States, Texas, Connecticut, Kentucky, California, Delaware, Maryland, Arizona, Pennsylvania
Time period: 2010-01-01--2013-01-01

The Criminal Justice Drug Abuse Treatment Studies 2 (CJ-DATS 2) was launched in 2008 with a focus on conducting implementation research in criminal justice settings. NIDA's ultimate goal for CJ-DATS 2 was to identify implementation strategies that maximize the likelihood of sustained delivery of evidence-based practices to improve offender drug abuse and HIV outcomes, and to decrease their risk of incarceration.

The Medication-Assisted Therapy (MAT) study focuses on implementing linkages to medication assisted treatment in correctional settings. During the study period community corrections staff engaged in training about addiction pharmacotherapies, while leadership in the corrections and treatment facilities engage in a joint strategic planning process to identify and resolve barriers to efficient flow of clients across the two systems.

This study includes 28 datasets and over 1,400 variables. The first five datasets for this study contain data on the baseline characteristics of the treatment and corrections sites that participated in the study as well as the characteristics of the staff working at those facilities. Opinions about Medication Assisted Treatment surveys were administered to personnel at the participating corrections and treatment sites (D6). Data on Inter-organization Relations between Probation and Parole staff with Treatment Providers were also collected (DS7-DS18).

Information was extracted from the charts of clients about their alcohol and opioid dependence as well as the referrals and treatment the clients received (DS19). Probation and parole officers and treatment providers were surveyed about monthly counts of referrals (DS20-DS21).

During the study 10 staff members from the community corrections agency and local treatment providers where MAT services were available were nominated to participate in a Pharmacotherapy Exchange Council (PEC). PEC members were involved with strategic planning for implementing changes to improve the usage of Medication-Assisted Therapy. PEC members were surveyed several times throughout the study.

PEC members completed surveys on how well the sites were adhering to the Organizational Linkages Intervention (OLI) process (DS22). Community corrections staff, PEC members and Connections Coordinators in the experimental group were surveyed about their perceptions of organizational benefits and costs associated with the MATICCE intervention (DS23). The PEC rated the Connections Coordinators (DS24)and the Connections Coordinators rate the PEC (DS25). PEC researchers completed surveys on how much of the OLI was completed (DS26) as well as what the sustainability of the changes made through the MATTICE project (DS27). The final dataset provides a key for who took the KPI (Key Performance Indicators) training and who was a PEC member (DS28).

Curated
Partially restricted
Simple Crosstabs

Criminal Justice Drug Abuse Treatment Studies (CJ-DATS) 2: Organizational Process Improvement Intervention (OPII), 2010-2013 [United States] (ICPSR 35082)

Released/updated on: 2015-08-07
Geographic coverage: Rhode Island, United States, Illinois, Colorado, Connecticut, Kentucky, Virginia, New Jersey, Arizona, Washington, Pennsylvania
Time period: 2010-01-01--2013-01-01

The Criminal Justice Drug Abuse Treatment Studies 2 (CJ-DATS 2) was launched in 2008 with a focus on conducting implementation research in criminal justice settings. NIDA's ultimate goal for CJ-DATS 2 was to identify implementation strategies that maximize the likelihood of sustained delivery of evidence-based practices to improve offender drug abuse and HIV outcomes, and to decrease their risk of incarceration.

The Organizational Process Improvement Intervention (OPII) study (aka Assessment study) focused on implementing assessment and treatment planning processes. Screening and assessment were used to identify substance abuse-related problems and to develop programming to address the problems so identified.

The OPII study engaged corrections and treatment agencies to improve the quality of interagency communication through the effective use of assessment and case planning processes and treatment referrals. Both inter-agency and intra-agency change processes were targeted. A multi-phase implementation protocol was used, wherein agencies engaged in team development, needs assessment, planning, implementation, and sustainability in distinct steps. Early- and delayed-start sites allowed the research team to control for effects of environmental changes within states. The protocol targeted critical communications channels between otherwise often highly segregated correctional and treatment agencies.

Evaluation of the OPII used a multi-site cluster randomized design with multiple measures over the course of the intervention. Clusters consisted of a criminal justice agency and one or more community treatment providers that received referrals from that criminal justice agency. Each of the 9 centers had two clusters (one had three), and each cluster was randomized to an Early-Start or a Delayed-Start condition with multiple measures over the course of the intervention. After randomization, the Early-Start sites began the OPII, while the Delayed-Start sites conducted business as usual, without any additional intervention. After approximately 12 months, or when the Early-Start change team completed the Implementation phase, the Delayed-Start change team began to carry out the protocol.

Throughout the study period different subsets of individuals working at correctional facilities and treatment programs at the study sites were asked to complete surveys. During the Baseline period of the study survey data were collected from correctional staff, correctional directors, treatment staff, treatment directors, correctional executives and treatment executives. These data can be found in (DS1-DS12). The executive respondents provided information at the organizational level for the programs they oversaw (DS5, DS6). Next, Needs Assessments were completed by the change teams and their facilitators (DS13-DS14). The change teams and facilitators also responded to surveys on Process Improvement Planning (DS15-DS19). During the Implementation stage, surveys were administered to select substance abuse treatment programs, change team facilitators, change team members and the immediate supervisors of the change team members (DS20-DS27). Selected correctional and treatment staff members (in the Early-Start sites only) were asked to complete Follow-up surveys at the end of the OPII process (DS28-DS33). Staff members who completed surveys also provided demographic data (DS36-DS41). DS42 is a restricted use version of DS41. Change team members kept track of the time they spent on OPII activities (DS35). Change team success was evaluated by a subset of raters (DS34).

Surveys were administered at 21 study sites and there was a total of over 2,700 survey respondents.

Curated

Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): Inmate Pre-Release Assessment (IPASS), 2001 [United States] (ICPSR 29201)

Released/updated on: 2011-01-06
Geographic coverage: Oregon, United States, New Mexico, California, Maryland
Time period: 2001-05-01--2001-07-01
The UCLA Integrated Substance Abuse Programs (ISAP), in conjunction with Texas Christian University, the University of Kentucky, and Brown University, proposes to develop and test the Inmate Pre-Release Assessment (IPASS) as a method of (1) prioritizing aftercare treatment need among graduates of prison-based substance abuse treatment programs, and (2) specifying an appropriate level of care (residential, outpatient, or self-help groups). The IPASS was developed specifically as a post-release risk measure for prison-based substance abuse treatment graduates by taking into account the inmates' historical drug use and criminal activity, as well as his or her performance during the prison-based treatment program. IPASS forms were administered to inmates housed in 14 institutions in four states: California, Maryland, New Mexico, and Oregon. While the IPASS has demonstrated sound psychometric properties as a continuous measure of post-release risk and general treatment need for substance-abusing parolees (Farabee & Knight, 2001), its ability to predict relapse and recidivism risk has not been tested using a prospective design. Part 1 of this study is the main part which is based on the IPASS Intake Form (479) and is designed to provide a quick assessment of criminal risk based on pre-incarceration risk factors. The first part of this form focuses heavily on criminal history, with questions about arrest and incarceration history, revocation history, and age of first criminal activity. It also asks about education level achieved, marital status and happiness, and friends drug use. The next part on the IPASS Intake Form (479) is designed to provide a quick screen for pre-incarceration drug use severity. It is based on the first ten items of the TCU Drug Screen II with the items corresponding to Diagnostic and Statistical Manual (DSM) classification criteria for Drug Dependence. And the last part of the IPASS Intake form begins by asking inmates if they want to enter a drug treatment program after leaving prison; and if so, which treatment modality is preferred. Inmates were asked to indicate how much they disagree or agree with nine items pertaining to their interactions with the treatment staff. These items include the treatment staff being easy to talk to, easy to understand, listening to you, organized and prepared, treating you with respect, helping you solve problems, supportive of your progress, helping you with your recovery, and happy with your progress. Part 2 of the study mainly focused on arrest information and the number of criminal activities. Part 3 of the study is based on the IPASS Continuing Care Referral Form (484) and begins by asking inmates if they want to enter a drug treatment program after leaving prison; and if so, which treatment modality is preferred. Part 4 of the study is based on the IPASS Continuing Care Admit/Discharge Form (481A) and provides information regarding the Admission and Discharge of the inmates. And finally, Part 5 of the study is completed by the inmates' primary counselor and begins by recording the number of "major" disciplinary acts an inmate committed prior to and during their time at the treatment program.
Curated

Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): National Criminal Justice Treatment Practices (NCJTP) Survey of Co-occurring Substance Use and Mental Disorder (COD) Treatment Services in Criminal Justice Settings, 2002-2008 (ICPSR 27962)

Released/updated on: 2011-08-10
Geographic coverage: United States
Time period: 2002-01-01--2008-01-01
A growing number of individuals in the criminal justice system suffer from co-occurring disorders (COD), the condition of simultaneous substance and mental disorders. As of yet, the population comprised of these individuals has not been thoroughly studied, despite the fact that COD-afflicted individuals pose unique clinical and administrative problems. The National Criminal Justice Treatment Practices (NCJTP) Survey of Co-occurring Substance Use and Mental Disorder (COD) Treatment Facilities in Criminal Justice Settings attempts to address the lack of information regarding the facets of COD in the criminal justice system. Data collected through this survey was subjected to statistical methods in order to analyze the relationship between COD treatment and organizational aspects. Specifically, from each treatment program, the survey collected data on the number of program participants, proportion of participants with various mental disorders, specific disorder screening instruments used, etc. As for the administrative aspect, the survey determined the division of COD treatment (e.g. one clinician providing both substance abuse and mental disorder treatment versus separate clinicians providing treatment), administrators' opinions of the differences between COD and non-COD participants, and accreditations held by the treatment program.
Curated

Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): National Criminal Justice Treatment Program (NCJTP) Survey in the United States, 2002-2008 (ICPSR 27382)

Released/updated on: 2010-08-09
Geographic coverage: District of Columbia, United States
Time period: 2002-01-01--2008-01-01
The National Criminal Justice Treatment Practices (NCJTP) Survey provides a comprehensive inquiry into the nature of programs and services provided to adult and juvenile offenders involved in the justice system in the United States. Participants included key criminal justice administrators, operations managers, and staff. This survey was conducted in all 50 states and the District of Columbia. The survey involved a myriad of state, regional, and local organizations employing a mix of their own staff and contracted personnel, and services that might involve multiple levels of government. It was a self-administrated, paper-and-pencil questionnaire. The methodology included a multilevel approach that captured the perspective of executives, front-line administrators, and line staff about current practices in a range of institutional and community correctional settings for adults and juveniles. The goals for this survey were: to describe current drug treatment practices, policies, and delivery systems for offenders on probation or parole supervision, and in jails, prisons, and youth institutions; to examine agency structures, resources, and other organizational factors that may affect service delivery, including mission, leadership, climate, culture, and beliefs about rehabilitation versus punishment; and to assess coordination and integration across criminal justice agencies and between corrections and treatment systems. Items in the survey included: respondent characteristics, organizational characteristics, correctional programs characteristics (e.g., size, nature, etc.), substance abuse treatment programs characteristics, social networks/agencies collaboration, integration of services with other agencies, attitudes toward punishment and rehabilitation (personal values), organizational needs assessment, organizational culture and climate for treatment, cynicism toward change, organizational commitment to treatment, and perspectives on intradepartmental coordination.
Curated

Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): The Criminal Justice Co-Occurring Disorder Screening Instrument (CJ-CODSI), 2002-2008 [United States] (ICPSR 27963)

Released/updated on: 2011-07-19
Geographic coverage: Rhode Island, United States, Texas, Colorado, California
Time period: 2002-01-01--2008-01-01
Currently, there exists an inadequacy in mental and substance use disorder screening instruments. This inadequacy stems from two reasons. First, the instruments are untested for widespread use with criminal justice populations. Second, most test for only one disorder at a time. The Criminal Justice Co-Occurring Disorder Screening Instrument (CODSI) study addresses this issue, investigating new methods by which to quickly, accurately, and easily evaluate individuals in the criminal justice population for COD (Co-Occurring Disorders). After determining that the Texas Christian University Drug Screen (TCUDS) would be the appropriate substance abuse screening component for a COD screen, researchers tested three possible mental disorder screening components: the Global Appraisal of Individual Needs (GSS, version 1.0); the Mental Health Screening Form (MHSF); and the Modified MINI Screen (MMS). The Structured Clinical Interview for DSM-IV (SCID), generally accepted as an accurate measure of mental disorder, was used as a reference by which to evaluate the three different screeners. Researchers also used items from the three different screeners to create two additional instruments: the CODSI-MD for any mental disorder and the CODSI-SMD for severe mental disorder. Actual testing was conducted at four different sites, taking a total of 280 new admissions to prison-based substance abuse treatment programs. Instruments were evaluated based on their sensitivity (ability to correctly identify those with COD), specificity (ability to correctly identify those without COD), and overall accuracy (percentage of correct identification across all people). Researchers also conducted a study using a sample comprised of a greater proportion of Latinos and African Americans, in order to evaluate the effect of race on the results of the instruments.
Curated

Developing a Timely Opioid Overdose Detection Tool through a Tribally Engaged Approach, United States, 2022-2024 (ICPSR 39278)

Released/updated on: 2024-12-11
Geographic coverage: United States
Time period: 2022-09-30--2024-09-29

The data files from this project are not available through NAHDAP/ICPSR. For information about accessing the data from this project, please contact the Principal Investigator.

Feedback from Tribal communities were gathered about a future Tribally specific near real-time opioid overdose monitoring dashboard. A questionnaire about an example dashboard with questions about overdose information, Narcan usage, and feedback about the dashboard's uses were included.

Curated

Drug Abuse Treatment Outcome Study--Adolescent (DATOS-A), 1993-1995: [United States] (ICPSR 3404)

Released/updated on: 2008-10-07
Geographic coverage: United States
Time period: 1993-01-01--1995-01-01
Drug Abuse Treatment Outcome Study - Adolescent (DATOS-A) was a multisite, prospective, community-based, longitudinal study of adolescents entering treatment. It was designed to evaluate the effectiveness of adolescent drug treatment by investigating the characteristics of the adolescent population, the structure and process of drug abuse treatment in adolescent programs, and the relationship of these factors with outcomes. Three major types or modalities of programs included in the study were chemical dependency or short-term inpatient (STI), therapeutic community or residential (RES), and outpatient drug-free (ODF). The adolescent battery of instruments included intake, intreatment, and follow-up questionnaires based largely on the DATOS adult study DRUG ABUSE TREATMENT OUTCOME STUDY (DATOS), 1991-1994: [UNITED STATES] (ICPSR 2258) instrument format, with considerable tailoring to the adolescent population. Clients entering treatment completed two comprehensive intake interviews (Intake 1 and Intake 2), approximately one week apart. This information is provided in Parts 1 and 2 of the data collection. These interviews were designed to obtain baseline data on drug use and other behaviors, such as illegal involvement, as well as information on background and demographic characteristics, education and training, mental health status, employment, income and expenditures, drug and alcohol dependence, health, religiosity and self-concept, and motivation and readiness for treatment. The one-, three-, and six-month intreatment interviews (Parts 3, 4, and 7) included items on treatment access, intreatment experience, and psychological functioning, as well as questions replicated from some of the domains in the Intake 1 and 2 questionnaires. The 12-month post-treatment follow-up interview (Part 5) included questions replicated from the previous interviews, and also included post-treatment status. Part 6 includes variables for time in treatment and interview availability indicators. The Measures Data (Part 8) were generated by using the Diagnostic and Statistical Manual of Mental Disorders (Rev. 3rd ed., DSM-III-R) (American Psychiatric Association, 1987). The variables in Part 8 give either the DSM-III-R level of dependence to a drug category or they describe whether the subject meets the DSM-III-R standard for a particular disorder. The 12-Month Follow-up Urine Result data (Part 9) provide the results from urine sample tests that were given to a sample of subjects at the time of the 12-Month Follow-up Interview. The urine test was used to ascertain the nature and extent of bias in the self-reports of the respondents. Urine specimens were tested for eight categories of drugs (amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine metabolite, methaqualone, opiates, and phencyclidine). The drugs covered in the study were alcohol, tobacco, marijuana (hashish, THC), cocaine (including crack), heroin, narcotics or opiates such as morphine, codeine, Demerol, Dilaudid, and Talwin, illegal methadone, sedatives and tranquilizers such as barbiturates and depressants, amphetamines or other stimulants such as speed or diet pills, methamphetamines, LSD, PCP, and other hallucinogens or psychedelics, and inhalants such as glue, gasoline, paint thinner, and aerosol sprays. The study also included drug of choice, frequency, and route of administration.
Curated

Drug Abuse Treatment Outcome Study (DATOS), 1991-1994: [United States] (ICPSR 2258)

Released/updated on: 2010-02-16
Geographic coverage: United States
Time period: 1991-01-01--1999-01-01

Drug-Abuse Treatment Outcomes Study (DATOS) is a prospective study designed to determine the outcomes of adult drug abuse treatment delivered in typical, stable, community-based programs and to provide comprehensive information on continuing and new questions about the effectiveness of drug abuse treatment for adults currently available in a variety of publicly funded and private programs. The study examined the role of treatment outcomes and program type, client characteristics (including dependence, treatment history, and physical and mental health comorbidities), treatment received (e.g., length and intensity of services provided), therapeutic approaches, provision of aftercare, and research on the components of effective treatment, including factors that engage and retain clients in programs. Four types of programs were included: outpatient methadone (OPM), short-term inpatient (STI), long-term residential (LTR), and outpatient drug-free (ODF). Respondents were sampled from among adults admitted to drug abuse treatment programs in 11 representative U.S. cities during 1991-1993.

Clients entering treatment completed two comprehensive intake interviews (Intake 1 and Intake 2), approximately one week apart. This information is provided in Parts 1 and 2 of the data collection. These interviews were designed to obtain baseline data on drug use and other behaviors, as well as information on background and demographic characteristics, patterns of dependence, living situation and child custody status, education and training, income and expenditures, and HIV risk behaviors, along with assessments of dependence, mental health, physical health, and social functioning. Data on criminal justice status and criminal behavior are reported in Part 5, Illegal Activities Data, and are drawn from the Intake 1 interview. Data reflecting during-treatment progress, including service delivery and client satisfaction, were collected in the one-, three-, and six-month in-treatment interviews (Parts 3, 4, and 8). The 12-Month Post-Treatment Follow-Up Interview (Part 6) replicated many of the intake questions and focused on key behaviors in the year following treatment. Part 7 includes variables for time in treatment and interview availability indicators. The 12-Month Follow-Up Urine Result data (Part 9) provide the results from urine sample tests that were given to a sample of subjects at the time of the 12-Month Follow-Up Interview. Urine specimens were tested for eight categories of drugs (amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine metabolite, methaqualone, opiates, and phencyclidine). The drugs covered in the study were alcohol, tobacco, marijuana (hashish, THC), hallucinogens or psychedelics such as LSD, mescaline, and PCP, cocaine (including crack), heroin, narcotics or opiates such as morphine, codeine, Demerol, Dilaudid, and Talwin, downers or depressants such as sedatives, barbiturates, and tranquilizers, amphetamines or other stimulants such as speed or diet pills, and other drugs. Part 10 contains data for 1393 clients who were interviewed 5 years post treatment. This part contains many of the same types of questions asked during previous interviews.

Curated

Drug Abuse Warning Network (DAWN), 1994: [United States] (ICPSR 2756)

Released/updated on: 2014-08-13
Geographic coverage: United States
The Drug Abuse Warning Network (DAWN) survey is designed to capture data on emergency department (ED) episodes that are induced by or related to the use of an illicit, prescription, or over-the-counter drug. For purposes of this collection, a drug "episode" is an ED visit that was induced by or related to the use of an illegal drug or the nonmedical use of a legal drug for patients aged six years and older. A drug "mention" refers to a substance that was mentioned during a drug-related ED episode. Because up to four drugs can be reported for each drug abuse episode, there are more mentions than episodes in the data. Individual persons may also be included more than once in the data. Within each facility participating in DAWN, a designated reporter, usually a member of the emergency department or medical records staff, was responsible for identifying drug-related episodes and recording and submitting data on each case. An episode report was submitted for each patient visiting a DAWN emergency department whose presenting problem(s) was/were related to their own drug use. DAWN produces estimates of drug-related emergency department visits for 50 specific drugs, drug categories, or combinations of drugs, including the following: acetaminophen, alcohol in combination with other drugs, alprazolam, amitriptyline, amphetamines, aspirin, cocaine, codeine, diazepam, diphenhydramine, fluoxetine, heroin/morphine, inhalants/solvents/aerosols, LSD, lorazepam, marijuana/hashish, methadone, methamphetamine, and PCP/PCP in combination with other drugs. The use of alcohol alone is not reported. The route of administration and form of drug used (e.g., powder, tablet, liquid) are included for each drug. Data collected for DAWN also include drug use motive and total drug mentions in the episode, as well as race, age, patient disposition, reason for ED visit, and day of the week, quarter, and year of episode.
Curated

Drug Abuse Warning Network (DAWN), 1997: [United States] (ICPSR 2834)

Released/updated on: 2014-08-13
Geographic coverage: United States
The Drug Abuse Warning Network (DAWN) survey is designed to capture data on emergency department (ED) episodes that are induced by or related to the use of an illicit, prescription, or over-the-counter drug. For purposes of this collection, a drug "episode" is an ED visit that was induced by or related to the use of an illegal drug or the nonmedical use of a legal drug for patients aged six years and older. A drug "mention" refers to a substance that was mentioned during a drug-related ED episode. Because up to four drugs can be reported for each drug abuse episode, there are more mentions than episodes in the data. Individual persons may also be included more than once in the data. Within each facility participating in DAWN, a designated reporter, usually a member of the emergency department or medical records staff, was responsible for identifying drug-related episodes and recording and submitting data on each case. An episode report was submitted for each patient visiting a DAWN emergency department whose presenting problem(s) was/were related to their own drug use. DAWN produces estimates of drug-related emergency department visits for 50 specific drugs, drug categories, or combinations of drugs, including the following: acetaminophen, alcohol in combination with other drugs, alprazolam, amitriptyline, amphetamines, aspirin, cocaine, codeine, diazepam, diphenhydramine, fluoxetine, heroin/morphine, inhalants/solvents/aerosols, LSD, lorazepam, marijuana/hashish, methadone, methamphetamine, and PCP/PCP in combination with other drugs. The use of alcohol alone is not reported. The route of administration and form of drug used (e.g., powder, tablet, liquid) are included for each drug. Data collected for DAWN also include drug use motive and total drug mentions in the episode, as well as race, age, patient disposition, reason for ED visit, and day of the week, quarter, and year of episode.
Curated

Drug Services Research Survey, 1990: [United States] (ICPSR 3393)

Released/updated on: 2008-10-08
Geographic coverage: United States
The Drug Services Research Survey (DSRS) was initiated to collect detailed information on the characteristics of drug treatment facilities and the clients discharged from those facilities in the United States. Data were collected between June and December of 1990 in two phases. In Phase I, facility-level information was gathered via telephone interviews with facility directors and drug treatment providers in a national sample of drug treatment facilities. The questionnaire included point prevalence estimates for March 30, 1990. Phase II involved site visits to a sample of Phase I facilities. This visit included an in-person interview with the facility director or administrator and the collection of client-level data from a sample of client records. Record abstractions were done for clients discharged from these facilities between September 1, 1989, and August 31, 1990. Follow-up of the clients to assess post-treatment status was conducted in the SERVICES RESEARCH OUTCOMES STUDY, 1995-1996: [UNITED STATES] (ICPSR 2691).
Curated

Drug Use Trajectories: Ethnic/Racial Comparisons, 1998-2002 [United-States] (ICPSR 30862)

Released/updated on: 2011-06-17
Geographic coverage: United States, Florida
Time period: 1998-01-01--2000-06-01, 2000-01-01--2002-04-01
Drug Use Trajectories is a two-wave panel study of noninstitutionalized young adults from South Florida that was designed to provide epidemiological estimates of drug use in early adulthood. In addition to a structured interview that measures lifetime prevalence of DSM-IV substance use and psychiatric disorders, the study included an extensive battery of measures that assessed lifetime and recent stress exposure, subsyndromal depression and anxiety, social support, and psychosocial risk and protective factors thought to be implicated in their etiology. This community-based epidemiological study was motivated by theoretical linkages between the social system, differential exposure of individuals within the system to social factors that can harm health, and to others that are protective, to explain persistent health disparities at the population level. The study assessed major depression, dysthymia, generalized anxiety disorder, social phobia, panic disorder, alcohol abuse and dependence, drug abuse and dependence, post-traumatic stress disorder, and antisocial personality disorder. Modules from the Diagnostic Interview Schedule (DIS) were included to assess the latter two disorders, and to assess AD/HD. Sub-clinical depression was measured using the Center for Epidemiologic Studies Depression scale (CES-D). The measures of stress exposure in the study involved four dimensions of stressful experience: recent life events, chronic stress, lifetime major and potentially traumatic events, and discrimination stress.
Curated
Restricted

The Dynamic Context of Teen Dating Violence in Adolescent Relationships, Baltimore, Maryland, 2014-2016 (ICPSR 36869)

Released/updated on: 2018-05-23
Geographic coverage: Baltimore, United States, Maryland
Time period: 2014-01-01--2016-01-01

These data are part of NACJD's Fast Track Release and are distributed as they were received from the data depositor. The files have been zipped by NACJD for release, but not checked or processed except for the removal of direct identifiers. Users should refer to the accompanying readme file for a brief description of the files available with this collection and consult the investigator(s) if further information is needed.

Teenage adolescent females residing in Baltimore, Maryland who were involved in a relationship with a history of violence were sought after to participate in this research study. Respondents were interviewed and then followed through daily diary entries for several months. The aim of the research was to understand the context regarding teen dating violence (TDV). Prior research on relationship context has not focused on minority populations; therefore, the focus of this project was urban, predominantly African American females.

The available data in this collection includes three SAS (.sas7bdat) files and a single SAS formats file that contains variable and value label information for all three data files. The three data files are:

  • final_baseline.sas7bdat (157 cases / 252 variables)
  • final_partnergrid.sas7bdat (156 cases / 76 variables)
  • hart_final_sas7bdata (7004 cases / 23 variables)
Curated

Dynamics of Retail Methamphetamine Markets in New York City, 2007-2009 (ICPSR 29821)

Released/updated on: 2014-01-06
Geographic coverage: New York City, United States, New York (state)
Time period: 2007-01-01--2009-12-31
The study was conducted to provide information about markets for, distribution of, and use of methamphetamine in New York City, both inside and outside of the MSM (men who have sex with men)/gay community. The study used Respondent Driven Sampling to recruit 132 methamphetamine market participants. Each respondent participated in a one to two hour structured interview combining both qualitative and quantitative responses. Each respondent was invited to recruit three additional eligible participants. Data collected included demographics, social network data, the respondent's market participation in obtaining and providing methamphetamine, consumption of methamphetamine, and experience with the criminal justice system and crime associated with participation in methamphetamine markets.
Curated

Epidemiologic Catchment Area Program Sites 1-4, 1979-1983 with National Death Index Data through 2007 (ICPSR 36621)

Released/updated on: 2017-10-17
Geographic coverage: North Carolina, Baltimore, New Haven, United States, Connecticut, Missouri, St. Louis, Durham, Maryland
Time period: 1979-01-01--1982-01-01, 1980-01-01--1983-01-01, 1979-01-01--2007-01-01

The Epidemiologic Catchment Area (ECA) program of research was initiated in response to the 1977 report of the President's Commission on Mental Health. The purpose was to collect data on the prevalence and incidence of mental disorders and on the use of and need for services by the mentally ill. Independent research teams at five universities (Yale University, Johns Hopkins University, Washington University, Duke University, and University of California at Los Angeles), in collaboration with the National Institute for Mental Health, conducted the studies with a core of common questions and sample characteristics. The sites were areas that had previously been designated as Community Mental Health Center catchment areas: New Haven, Connecticut, Baltimore, Maryland, St. Louis, Missouri, Durham, North Carolina, and Los Angeles, California. Each site sampled over 3,000 community residents and 500 residents of institutions, yielding 20,861 respondents overall. The longitudinal ECA design incorporated two waves of personal interviews administered one year apart and a brief telephone interview in between (for the household sample). The diagnostic interview used in the ECA was the NIMH Diagnostic Interview Schedule (DIS), Version III (with the exception of the Yale Wave I survey, which used Version II). Diagnoses were categorized according to the DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, 3rd Edition (DSM-III). Diagnoses derived from the DIS include manic episode, dysthymia, bipolar disorder, single episode major depression, recurrent major depression, atypical bipolar disorder, alcohol abuse or dependence, drug abuse or dependence, schizophrenia, schizophreniform, obsessive compulsive disorder, phobia, somatization, panic, antisocial personality, and anorexia nervosa. The DIS uses the Mini-Mental State Examination (MMSE), which measures cognitive functioning, as an indirect measure of the DSM-III Organic Mental Disorders. In the ECA survey, this diagnosis is called cognitive impairment.

This collection features data from 17,327 participants across 2,005 variables. Data from the Los Angeles, California, Catchment (UCLA) are not included. Baseline data (Wave 1) and Wave 2 data were linked to the National Death Index through 2007, which includes primary and contributing causes of death, International Classification of Disease (ICD) codes, and nature of injury variables.

Curated

Evaluation of the Adolescent Portable Therapy (APT) Program [New York City], 2001-2004 (ICPSR 4299)

Released/updated on: 2005-11-04
Geographic coverage: New York City, United States, New York (state)
Time period: 2001-01-01--2004-01-01
This study contains data collected for an evaluation of the Adolescent Portable Therapy (APT) Program, which provided family-based drug treatment services to adolescents involved with the New York City juvenile justice system on charges of Persons In Need of Supervision (PINS) or delinquency. The program aimed to improve five core areas of the young peoples' lives: substance use, mental health, schooling, family functioning, and recidivism. Recruitment for the study occurred at juvenile detention facilities in New York City. Intake staff conducted screening interviews with the detainees. Those who reported using substances at least 30 times in the previous 30 days, or who met Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM IV) criteria for substance abuse or dependence were eligible for selection. After the respondents and their families consented to participate, the respondents were randomly assigned to treatment and control groups. The treatment group went on to receive services from APT, while control group subjects received no APT services but had access to all other standard facilities and community based services. The evaluation participants were interviewed at four time points: at intake into the study in the juvenile detention facilities (baseline), three months after release from detention (T1), nine months after release from detention (T2), and 15 months after release from detention (T3). Whenever subjects were interviewed outside of a detention facility for T1, T2, and T3, study staff attempted to collect urine samples which were tested for marijuana, cocaine, amphetamines, phencyclidine (PCP), and opiates. Topics covered by the interviews included substance use and treatment, physical health, risk behaviors and disease prevention, mental and emotional health, living situation and environment, crime and legal issues, school, work, income, and demographic characteristics.
Curated

Exploring the Drugs-Crime Connection Within the Electronic Dance Music and Hip Hop Nightclub Scenes in Philadelphia, Pennsylvania, 2005-2006 (ICPSR 21187)

Released/updated on: 2013-01-15
Geographic coverage: United States, Philadelphia, Pennsylvania
Time period: 2005-04-01--2006-12-01
To explore the relationship between alcohol, drugs, and crime in the electronic dance music and hip hop nightclub scenes of Philadelphia, Pennsylvania, researchers utilized a multi-faceted ethnographic approach featuring in-depth interviews with 51 respondents (Dataset 1, Initial Interview Qualitative Data) and two Web-based follow-up surveys with respondents (Dataset 2, Follow-Up Surveys Quantitative Data). Recruitment of respondents began in April of 2005 and was conducted in two ways. Slightly more than half of the respondents (n = 30) were recruited with the help of staff from two small, independent record stores. The remaining 21 respondents were recruited at electronic dance music or hip hop nightclub events. Dataset 1 includes structured and open-ended questions about the respondent's background, living situation and lifestyle, involvement and commitment to the electronic dance music and hip hop scenes, nightclub culture and interaction therein, and experiences with drugs, criminal activity, and victimization. Dataset 2 includes descriptive information on how many club events were attended, which ones, and the activities (including drug use and crime/victimization experiences) taking place therein. Dataset 3 (Demographic Quantitative Data) includes coded demographic information from the Dataset 1 interviews.
Curated

Gender, Mental Illness, and Crime in the United States, 2004 (ICPSR 27521)

Released/updated on: 2011-02-10
Geographic coverage: United States
The purpose of the study was to examine the gendered effects of depression, drug use, and treatment on crime and the effects of interaction with the criminal justice system on subsequent depression and drug use. The data for the study are from the NATIONAL HOUSEHOLD SURVEY ON DRUG USE AND HEALTH (NSDUH), 2004 [ICPSR 4373]. In addition to the 2004 NSDUH data, the study utilized new variables that were derived from the original dataset by the principal investigator, namely recoded variables, interaction variables, and computed indices. Information was provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 years and older. Respondents also provided detailed information regarding criminal activity, depression, and other factors. A total of 55,602 respondents participated in the study. The dataset contains a total of 3,011 variables. The first 2,690 variables are drawn from the 2004 NSDUH dataset and the remaining 321 variables were created by the principal investigator. Variables created by the principal investigator are manipulations of the first 2,690 variables. Specifically, these variables include depression indices, drug dependence indicators, interactions with gender and other demographic variables, and dichotomous recoded variables relating to types of drug abuse and criminal behavior.
Curated

The Great Smoky Mountains Study (GSMS): Alcohol, Cannabis, Depression Disorders, North Carolina, 1992-2003 (ICPSR 37221)

Released/updated on: 2018-12-12
Geographic coverage: North Carolina, United States
Time period: 1992-01-01--2003-01-01

The Great Smoky Mountain Study (GSMS) is a longitudinal epidemiological study of 1,420 children begun in 1992 in 11 rural counties in western North Carolina. Originally, the study had three aims: 1) to estimate the prevalence of common psychiatric disorders; 2) to study their development over time; and 3) to determine the level of mental health service use. The study expanded over time to include correlates and predictors of substance abuse and psychiatric problems. The study continued for over 20 years, with the original participants assessed up to 11 times from ages 9 to 30 (over 11,000 assessments total).

This collection includes data from study modules related to alcohol, cannabis, and depressive disorders in addition to core data on participants. This core data includes demographic variables related to age, sex, socioeconomic status, and race.

Curated
Partially restricted

Harvard School of Public Health College Alcohol Study, 1993 (ICPSR 6577)

Released/updated on: 2020-01-30
Geographic coverage: United States
This survey focused on alcohol use and alcohol problems among undergraduate college students. The survey collected information on students' use of alcohol, tobacco, and illicit drugs, views on campus alcohol policies and student alcohol use, reasons for drinking alcohol and reasons for not drinking or limiting drinking, and personal difficulties caused by drinking problems (e.g., missed classes, injury, and trouble with police). Additional topics covered by the survey include overall health status, daily activities, satisfaction with education being received, grade-point average, living arrangements, social life, sexual activity, use of condoms during sexual intercourse, date rape, drunk driving, and attendance in meetings of Alcoholics Anonymous, Alanon, Adult Children of Alcoholics, and Narcotics Anonymous. Background variables include age, height, weight, sex, marital status, religion, mother's and father's education, mother's and father's drinking habits, race, and Hispanic origin.
Curated
Partially restricted

Harvard School of Public Health College Alcohol Study, 1997 (ICPSR 3163)

Released/updated on: 2020-01-30
Geographic coverage: United States
This study resurveyed colleges that participated in the HARVARD SCHOOL OF PUBLIC HEALTH COLLEGE ALCOHOL STUDY, 1993 (ICPSR 6577). As in the 1993 survey, this survey focused on alcohol use and alcohol problems among undergraduate college students. The survey collected information on students' use of alcohol, tobacco, and illicit drugs, views on campus alcohol policies and student alcohol use, reasons for drinking alcohol and reasons for not drinking or limiting drinking, and personal difficulties caused by drinking problems (e.g., missed classes, injury, and trouble with police). Additional topics covered by the survey include overall health status, daily activities, satisfaction with education being received, grade-point average, living arrangements, social life, sexual activity, use of condoms during sexual intercourse, date rape, drunk driving, and attendance in meetings of Alcoholics Anonymous, Alanon, Adult Children of Alcoholics, and Narcotics Anonymous. Background variables include age, sex, marital status, religion, mother's and father's drinking habits, race, and Hispanic origin.
Curated
Partially restricted

Harvard School of Public Health College Alcohol Study, 1999 (ICPSR 3818)

Released/updated on: 2020-01-30
Geographic coverage: United States
This survey interviewed students at colleges that participated in the first two rounds of the HARVARD SCHOOL OF PUBLIC HEALTH COLLEGE ALCOHOL STUDY, which were conducted in 1993 and 1997 (ICPSR 6577 and 3163). As in the previous surveys, the 1999 survey focused on alcohol use and alcohol problems among undergraduate college students. The survey collected information on students' use of alcohol, tobacco, and illicit drugs, views on campus alcohol policies and student alcohol use, reasons for drinking alcohol and reasons for not drinking or limiting drinking, and personal difficulties caused by drinking problems (e.g., missed classes, trouble with police, and health problems). Additional topics covered by the survey include overall health status, daily activities, satisfaction with education being received, grade-point average, living arrangements, social life, sexual activity (heterosexual, homosexual, and bisexual), use of condoms during sexual intercourse, date rape, drunk driving, and attendance in meetings of Alcoholics Anonymous. Background variables include age, height, weight, sex, marital status, religion, mother's and father's education, mother's and father's drinking habits, race, and Hispanic origin.
Curated
Partially restricted

Harvard School of Public Health College Alcohol Study, 2001 (ICPSR 4291)

Released/updated on: 2008-02-05
Geographic coverage: United States
The Harvard School of Public Health College Alcohol Study (CAS), a multi-round survey that interviewed students in four-year colleges, examined key issues in alcohol abuse and other high risk behaviors among college students, including the relationship of state alcohol control measures and college policies to alcohol use and the role of fraternities and sororities, easy access to alcohol, and low alcohol prices. As in the previous rounds of CAS, which were conducted in 1993 (ICPSR 6577), 1997 (ICPSR 3163), and 1999 (ICPSR 3818), this round collected information on students' use of alcohol, tobacco, and illicit drugs, views on campus alcohol policies and student alcohol use, reasons for drinking alcohol and reasons for not drinking or limiting drinking, and personal difficulties caused by drinking problems (e.g., missed classes and trouble with police). Additional topics covered by the survey include overall health status, daily activities, satisfaction with education being received, grade-point average, living arrangements, social life, sexual activity (heterosexual, homosexual, and bisexual), use of condoms during sexual intercourse, rape, and drunk driving. Background variables include age, height, weight, sex, marital status, religion, mother's and father's education, mother's and father's drinking habits, race, and Hispanic origin.
Curated

Health Consequences of Long-Term Injection Heroin Use Among Aging Mexican American Men in Houston, Texas, 2008 - 2011 [Restricted-use Files] (ICPSR 34896)

Released/updated on: 2015-01-21
Geographic coverage: United States, Texas
Time period: 2008-01-01--2011-01-01

The study is comprised of interviews from 227 Hispanic males aged 45 or older living in the area of Houston, Texas to address the gaps in knowledge on the social factors and health consequences of injection heroin use among aging Mexican American males. Specifically, the study investigated how the life course transitions of incarceration and drug treatment and drug abuse and family trajectories affect both the heroin career status and health consequences of these aging Mexican American men.

The study used a cross-sectional, field-intensive outreach methodology augmented with respondent-driven sampling. Recruitment was focused in two Houston neighborhoods that are predominantly Mexican American areas with high rates of crime, poverty, and psychosocial challenges. Trained Outreach Specialists familiar with these communities identified community gatekeepers and gained their trust through continued presence in the community and ongoing dialogue about the study. These gatekeepers then helped identify individuals meeting the inclusion criteria: Mexican American men aged 45 years or older with a history of injection drug use for at least 3 years. The men were then classified into one of three groups: current injectors (current group), former injectors not in treatment (former group), or former injectors currently enrolled in methadone maintenance treatment programs (MMTP group).

The second part is a second survey asking questions about social networks the respondent participates in. Questions ask the respondent to answer on one individual in their network and answer questions about that person and their interaction with them. Questions include basic demographics, history injecting drugs and sexual contact with the person.

Curated
Simple Crosstabs

Improving Health and Employment Outcomes Through Workplace Opioid Policies, United States, 2022-2023 (ICPSR 38967)

Released/updated on: 2024-03-13
Geographic coverage: United States
Time period: 2022-06-30--2023-03-01
This study developed and tested the feasibility of implementing guidelines on workplace policies to reduce prescription opioid use, decrease chronic opioid use, promote recovery from opioid use disorder, and improve health-related employment outcomes. The researchers developed and tested these guidelines among construction workers. This project provided critical information to design and conduct a randomized trial to implement and evaluate insurance and employment policy guidelines among labor-management health funds in the building trades.

This study is also available on the HEAL Data Platform (study record HDP00331).

Curated

The Iowa Adoption Studies, 1975-2008 (ICPSR 34369)

Released/updated on: 2020-11-09
Geographic coverage: Iowa, United States
Time period: 1975-01-01--2008-01-01

The Iowa Adoption Studies were conducted between 1975 and 2008. The group of studies consist of 5 independent waves of data collection each of which examined genetic (biological) and environmental influences on psychopathology. The adoption paradigm allowed separation of genetic and environmental influences on behavior, as well as joint influences due to gene x environment interaction. Adoptees were interviewed about lifetime psychopathology including substance abuse and dependence, antisocial personality, and mood disorders. A follow-up study was conducted from 2000-2004 that recruited all previous participants and natural offspring of the adoptive parents when available. Standardized psychiatric assessments were administered along with measures of personality disorders and traits, retrospective reports on childhood experiences with adoptive parents, and current symptomatology. An extensive neurocognitive assessment was conducted on a subset of participants who had standardized school achievement scores. The goal of this last wave of assessment was to evaluate the influence of substance use on mid-life cognition and health.

The respondents were assessed using a number of different surveys over the study period. The following describes the notable variables as well as descriptions of the surveys included in the dataset.

The first variables in the dataset identify sibling pairs and provides data on whether the respondents' biological parents suffered from mental health or substance abuse issues. Next birth records are provided that give basic information about the health of the person when he or she was born. This information is followed by the survey results of "The Schedule for Nonadaptive and Adaptive Personality" (SNAP) as well as variables that reflect the diagnosis of personality disorders and nonadaptive personality traits based on the SNAP survey responses.

The next section includes responses from "The Iowa Personality Disorder Screen," a quick personality disorder screen developed in 1999 intended for use in clinical and research settings.

Next, responses to Pearson Assessments "Brief symptoms inventory" are included as well as the scores calculated based on these survey responses. The results of this survey assess the mental state of the patient including scales on Somatization, Obsessive-Compulsive, Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation and Psychoticism.

The respondents also completed the "Buss-Durkee Hostility Questionnaire" and were assessed on measure regarding the following hostility traits: negativism, resentment, indirect hostility, assault, suspicion, irritability and verbal hostility.

Reponses to the "The Social Provisions Scale" survey are also included. The purpose of this survey is to assess the relationship the respondents have to other people. The 6 social provisions assessed include: guidance, reliable alliance, reassurance of worth, attachment, social integration, and opportunity for nurturance.

"The Parental Bonding Instrument" instrument was utilized to assess the respondents' relationships to their mothers and fathers.

A series of cognitive tests were administered to respondents. ICPSR is unable to provide the survey instruments used in the cognitive test due to copy write issues. These tests include:

Controlled Oral Word Association Test (COWAT)

North American Adult Reading Test (NAART)

Rey Figure and Rey Complex Figure Test and Recognition Trial (RCFT)

Shipley Institute of Living Scale (SILS)

Stroop Color and Word Test (SCWT)

Tower of Hanoi (TofH)

Comprehensive Trailmaking Test (CTMT)

Weschler Adult Intelligence Test (WAIS)

Weschler Memory Test (WMS)

The dataset also includes respondents' results of the Comprehensive Performance Test (CPT) and the Iowa Gambling Task (IGT)

Scores from the "Iowa Test of Basic Skills," a test of academic achievement that evaluates students knowledge in subjects including, mathematics, reading comprehension, and science, are included in the dataset. Respondents are evaluated in grades 4, 8 and 11.

The final section of the dataset includes two waves of the "Semi Structured Assessment for the Genetics of Alcoholism," a survey intended to assess the physical, psychological, and social manifestations of alcohol abuse. These survey responses make up the bulk of the dataset and include variables on a variety of topics including: demographics, medical history, substance use, eating disorders, depression, dysthymia, mania, ASP, suicide, PTSD, generalized anxiety disorder, OCD, social phobia, agoraphobia, panic disorder, home environment, gambling, and ADHD. Substances use investigated includes alcohol, tobacco, marijuana, sedatives, stimulants, cocaine, opiates, solvents, hallucinogens, and other drugs.

This dataset includes 934 cases and 9,370 variables.

Curated
Partially restricted
Simple Crosstabs

Mindful Body Awareness Training for Medication for Opioid Use Disorder (MOUD), Pacific Northwest, 2019-2024 (ICPSR 39235)

Released/updated on: 2025-06-19
Geographic coverage: United States
Time period: 2019-08-01--2024-01-31
The national opioid epidemic requires development of real-world evidence-based treatments for opioid use disorder, including adjuncts to Medication for Opioid Use Disorder (MOUD). Interventions are needed that address the complex needs of patients with opioid use disorder, which include substantial mental health co-morbidity and high rates of chronic pain. This study tested a mind-body intervention, Mindful Awareness in Body-oriented Therapy (MABT), as an adjunct to MOUD across multiple community outpatient clinical settings. MABT, a mindfulness-based intervention, addresses aspects of awareness, interoception, and regulation that may be associated with pain, mental health distress, and behavioral control that increase risk of relapse and poor treatment outcomes.
Curated

Monitoring Drug Epidemics and the Markets That Sustain Them, Arrestee Drug Abuse Monitoring (ADAM) and ADAM II Data, 2000-2003 and 2007-2010 (ICPSR 33201)

Released/updated on: 2012-12-13
Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis
Time period: 2000-01-01--2003-01-01, 2007-01-01--2010-01-01
This study examined trends in the use of five widely abused drugs among arrestees at 10 geographically diverse locations from 2000 to 2010: Atlanta, Charlotte, Chicago, Denver, Indianapolis, Manhattan, Minneapolis, Portland Oregon, Sacramento, and Washington DC. The data came from the Arrestee Drug Abuse Monitoring Program reintroduced in 2007 (ADAM II) and its predecessor the ADAM program. ADAM data included urinalysis results that provided an objective measure of recent drug use, provided location specific estimates over time, and provided sample weights that yielded unbiased estimates for each location. The ADAM data were analyzed according to a drug epidemics framework, which has been previously employed to understand the decline of the crack epidemic, the growth of marijuana use in the 1990s, and the persistence of heroin use. Similar to other diffusion of innovation processes, drug epidemics tend to follow a natural course passing through four distinct phases: incubation, expansion, plateau, and decline. The study also searched for changes in drug markets over the course of a drug epidemic.
Curated

Multi-Site Adult Drug Court Evaluation (MADCE), 2003-2009 (ICPSR 30983)

Released/updated on: 2012-11-05
Geographic coverage: North Carolina, New York, United States, Illinois, Georgia, Florida, Washington, South Carolina, Pennsylvania
Time period: 2004-02-01--2004-06-01, 2005-03-01--2006-06-01, 2005-08-01--2006-12-01, 2006-09-01--2008-01-01, 2006-09-01--2008-01-01

The Multi-Site Adult Drug Court Evaluation (MADCE) study included 23 drug courts and 6 comparison sites selected from 8 states across the country. The purpose of the study was to: (1) Test whether drug courts reduce drug use, crime, and multiple other problems associated with drug abuse, in comparision with similar offenders not exposed to drug courts, (2) address how drug courts work and for whom by isolating key individual and program factors that make drug courts more or less effective in achieving their desired outcomes, (3) explain how offender attitudes and behaviors change when they are exposed to drug courts and how these changes help explain the effectiveness of drug court programs, and (4) examine whether drug courts generate cost savings.

Offenders in all 29 sites were surveyed in 3 waves, at baseline, 6 months later, and 18 months after enrollment. The research comprises three major components: process evaluation, impact evaluation, and a cost-benefit analysis. The process evaluation describes how the 23 drug court sites vary in program eligibility, supervision, treatment, team collaboration, and other key policies and practices. The impact evaluation examines whether drug courts produce better outcomes than comparison sites and tests which court policies and offender attitudes might explain those effects. The cost-benefit analysis evaluates drug court costs and benefits.

Curated
Simple Crosstabs

National Comorbidity Survey: Reinterview (NCS-2), 2001-2002 (ICPSR 35067)

Released/updated on: 2015-03-31
Geographic coverage: United States
Time period: 2001-01-01--2002-01-01

The NCS-2 was a re-interview of 5,001 individuals who participated in the Baseline (NCS-1). The study was conducted a decade after the initial baseline survey. The aim was to collect information about changes in mental disorders, substance use disorders, and the predictors and consequences of these changes over the ten years between the two surveys. The collection contains three major sections: the main survey, demographic data, and diagnostic data.

In the main survey, respondents were asked about general physical and mental health. Questions focused on a variety of health issues, including limitations caused by respondents' health issues, substance use, childhood health, life-threatening illnesses, chronic conditions, medications taken in the past 12 months, level of functioning and symptoms experienced in the past 30 days, and any services used by the respondents since the (NCS-1). Additional questions focused on mental disorders including depression, bipolar disorder, specific and social phobias, generalized anxiety, intermittent explosive disorder, suicidality, post-traumatic stress disorder, neurasthenia, pre-menstrual dysphoric disorder, attention deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and separation anxiety. Respondents were also asked about their lives in general, with topics including employment, finances, marriage, children, their social lives, and stressful life events experienced in the past 12 months. Additionally, two personality assessments were included consisting of respondents' opinions on whether various true/false statements accurately described their personalities. Another focus of the main survey dealt with substance use and abuse, nonmedical use of prescription drugs, and polysubstance use. Interview questions in the NCS-2 Main Survey were customized to each respondent based on previous responses in the Baseline (NCS-1).

The middle section contains demographic and other background information including age, education, employment, household composition, household income, marital status, and region.

The last section of the collection focused on whether respondents met diagnostic criteria for psychological disorders asked about in the main survey.

Curated

National Comorbidity Survey: Reinterview (NCS-2), 2001-2002 [Restricted-Use] (ICPSR 30921)

Released/updated on: 2024-03-04
Geographic coverage: United States
Time period: 2001-01-01--2002-01-01

The NCS-2 was a re-interview of 5,001 individuals who participated in the Baseline (NCS-1). The study was conducted a decade after the initial baseline survey. The aim was to collect information about changes in mental disorders, substance use disorders, and the predictors and consequences of these changes over the ten years between the two surveys. The collection contains four major sections: the main survey, demographic data, diagnostic data, and state, county, and tract FIPS data.

In the main survey, respondents were asked about general physical and mental health. Questions focused on a variety of health issues, including limitations caused by respondents' health issues, substance use, childhood health, life-threatening illnesses, chronic conditions, medications taken in the past 12 months, level of functioning and symptoms experienced in the past 30 days, and any services used by the respondents since the (NCS-1). Additional questions focused on mental disorders including depression, bipolar disorder, specific and social phobias, generalized anxiety, intermittent explosive disorder, suicidality, post-traumatic stress disorder, neurasthenia, pre-menstrual dysphoric disorder, attention deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and separation anxiety. Respondents were also asked about their lives in general, with topics including employment, finances, marriage, children, their social lives, and stressful life events experienced in the past 12 months. Additionally, two personality assessments were included consisting of respondents' opinions on whether various true/false statements accurately described their personalities. Another focus of the main survey dealt with substance use and abuse, nonmedical use of prescription drugs, and polysubstance use. Interview questions in the NCS-2 Main Survey were customized to each respondent based on previous responses in the Baseline (NCS-1).

The second part contains demographic and other background information including age, education, employment, household composition, household income, marital status, and region.

The third part focuses on whether respondents met diagnostic criteria for psychological disorders asked about in the main survey.

The fourth part contains respondents' state, county, and tract FIPS data.